Warning: Creating default object from empty value in /home/altaywgm/public_html/wp-content/plugins/gaviasframework/redux/redux-framework/inc/class.redux_filesystem.php on line 29
New Indication: Pembrolizumab for her2-positive gastric/GEJ adenoCa - Altai Oncology
  1. Home /
    2. Altai Protocol Library /
  2. New Indication: Pembrolizumab for her2-positive gastric/GEJ adenoCa

Altai Protocol Library

1041 protocols and counting

All protocols with references and links

All protocols reviewed by a Medical Oncologist/Hematologist

All protocols in major guidelines included

Ability to create your own protocols

Kütüphanede Ara Ara
Altai Protocol Library

New Indication: Pembrolizumab for her2-positive gastric/GEJ adenoCa

New Indication: Pembrolizumab for her2-positive gastric/GEJ adenoCa
Study:
  • Randomized, double-blind phase III study (KEYNOTE-811)
  • First-line treatment for metastatic her2-positive gastric or GEJ adenocarcinoma
  • Chemotherapy + trastuzumab + pembrolizumab (n=133) vs. chemotherapy + trastuzumab + placebo (n=131)
  • Chemotherapy: Investigator’s choice of CISplatin + 5FU or CapeOX
Efficacy:
  • CRR: 11% vs. 3%
  • ORR: 74% [66%-82%] vs. 52% [43%-61%] (p < 0.0001)
  • DoR: 10.6 mos vs. 9.5 mos
Safety:
  • Safety results not published yet

FDA package insert

FDA package insert (not published yet)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125514s097lbl.pdf

Altai Chemo Planner

Quickly Prepare Accurate Chemotherapy Orders

Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.

Learn More